# Suzhou Bangqi Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-bangqi-biotechnology-co

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.bangqbio.com
- Latest round: Series B (Nov 28, 2024)
- Investors on record: 5

## About

Established in 2020 and based in Suzhou, China, Suzhou Bangqi Biotechnology Co., Ltd. operates as a medical instrument developer that focuses on the development and production of in vitro diagnostic products. It was recognized as the National High-tech Enterprises. In November 2024, Suzhou Bangqi Biotechnology Co., Ltd. closed a series B funding.

The company provides fully automated immunoblot analyzers and kits. Fully automated immunoblot analyzers include sample modules, incubation modules, image acquisition modules, software systems, etc. Kit is divided into autoimmune products and allergen products, such as immunone-phropathy antibodies, sex hormone antibodies, and food allergens.

The company generates revenue by selling in vitro diagnostic products.

## Funding rounds

- Series B, Nov 28, 2024 — Zhangjiagang Industrial Capital Center, Jinxin Capital
- Series A, Aug 8, 2023 — QF Capital, Step Fund
- Series A, Jun 6, 2022 — Step Fund, Honest Capital

## Investors

- Step Fund (https://capitalatlas.ai/funds/step-fund) — Series A
- Honest Capital (https://capitalatlas.ai/funds/honest-capital) — Series A
- QF Capital (https://capitalatlas.ai/funds/qf-capital) — Series A
- Zhangjiagang Industrial Capital Center (https://capitalatlas.ai/funds/zhangjiagang-industrial-capital-center) — Series B
- Jinxin Capital — Series B